Guggenheim Capital LLC Avid Bioservices, Inc. Transaction History

Guggenheim Capital LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$11.63 - $21.55 $112,136 - $207,785	9,642 Added 95.72%	19,715 $301,000
Q1 2022 May 16, 2022	BUY	$16.63 - $27.73 $1,230 - $2,052	74 Added 0.74%	10,073 $205,000
Q4 2021 Feb 14, 2022	BUY	$20.7 - $34.18 $206,979 - $341,765	9,999 New	9,999 $292,000
Q2 2018 Aug 14, 2018	SELL	$3.1 - $3.93 $37,317 - $47,309	-12,038 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$2.32 - $4.22 $27,928 - $50,800	12,038 New	12,038 $35,000

188

68.4M

89.9K

118K

Ticker CDMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,167,500
Market Cap $776M
Description
Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Guggenheim Capital LLC with notifications on news.